Pharmacokinetic and pharmacodynamics evaluation of ceftobiprole medocaril for the treatment of hospital-acquired pneumonia.

Lagacé-Wiens PR, Rubinstein E

Open source

DOI
10.1517/17425255.2013.788150
Published
2013 Jun
Container
Expert opinion on drug metabolism & toxicology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1517/17425255.2013.788150,
  title = {Pharmacokinetic and pharmacodynamics evaluation of ceftobiprole medocaril for the treatment of hospital-acquired pneumonia.},
  author = {Lagacé-Wiens PR and Rubinstein E},
  year = {2013},
  journal = {Expert opinion on drug metabolism \& toxicology},
  doi = {10.1517/17425255.2013.788150},
  url = {https://doi.org/10.1517/17425255.2013.788150}
}

RIS

TY  - JOUR
TI  - Pharmacokinetic and pharmacodynamics evaluation of ceftobiprole medocaril for the treatment of hospital-acquired pneumonia.
AU  - Lagacé-Wiens PR
AU  - Rubinstein E
PY  - 2013
JO  - Expert opinion on drug metabolism & toxicology
DO  - 10.1517/17425255.2013.788150
UR  - https://doi.org/10.1517/17425255.2013.788150
ER  - 

APA

PR, L., & E, R. (2013). Pharmacokinetic and pharmacodynamics evaluation of ceftobiprole medocaril for the treatment of hospital-acquired pneumonia.. Expert opinion on drug metabolism & toxicology. https://doi.org/10.1517/17425255.2013.788150

Source records